BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29555909)

  • 1. Differential expression pattern of co-inhibitory molecules on CD4
    Abel A; Steeg C; Aminkiah F; Addai-Mensah O; Addo M; Gagliani N; Casar C; Yar DD; Owusu-Dabo E; Jacobs T; Mackroth MS
    Sci Rep; 2018 Mar; 8(1):4789. PubMed ID: 29555909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
    Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
    Front Immunol; 2020; 11():1870. PubMed ID: 32983106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells expressing multiple co-inhibitory molecules in acute malaria are not exhausted but exert a suppressive function in mice.
    Brandi J; Lehmann C; Kaminski LC; Schulze Zur Wiesch J; Addo M; Ramharter M; Mackroth M; Jacobs T; Riehn M
    Eur J Immunol; 2022 Feb; 52(2):312-327. PubMed ID: 34752634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Evidence of T Cell Exhaustion and Senescence During Symptomatic
    Frimpong A; Kusi KA; Adu-Gyasi D; Amponsah J; Ofori MF; Ndifon W
    Front Immunol; 2019; 10():1345. PubMed ID: 31316497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion.
    Illingworth J; Butler NS; Roetynck S; Mwacharo J; Pierce SK; Bejon P; Crompton PD; Marsh K; Ndungu FM
    J Immunol; 2013 Feb; 190(3):1038-47. PubMed ID: 23264654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis.
    Lavon I; Heli C; Brill L; Charbit H; Vaknin-Dembinsky A
    Front Immunol; 2019; 10():835. PubMed ID: 31134049
    [No Abstract]   [Full Text] [Related]  

  • 7. CTLA-4 positive T cells in contrast to procalcitonin plasma levels discriminate between severe and uncomplicated Plasmodium falciparum malaria in Ghanaian children.
    Braun N; Marfo Y; Von Gärtner C; Burchard GD; Zipfel PF; Browne NE; Fleischer B; Bröker BM
    Trop Med Int Health; 2003 Nov; 8(11):1018-24. PubMed ID: 14629769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Seasonal Malaria Chemoprevention on Immune Markers of Exhaustion and Regulation.
    Attaher O; Zaidi I; Kwan JL; Issiaka D; Samassekou MB; Cisse KB; Coulibaly B; Keita S; Sissoko S; Traore T; Diarra K; Diarra BS; Dembele A; Kanoute MB; Mahamar A; Barry A; Fried M; Dicko A; Duffy PE
    J Infect Dis; 2020 Jan; 221(1):138-145. PubMed ID: 31584094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor Function.
    Mackroth MS; Abel A; Steeg C; Schulze Zur Wiesch J; Jacobs T
    PLoS Pathog; 2016 Nov; 12(11):e1005909. PubMed ID: 27802341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T Cell-Derived Granzyme B Is Increased in Severe
    Kaminski LC; Riehn M; Abel A; Steeg C; Yar DD; Addai-Mensah O; Aminkiah F; Owusu Dabo E; Jacobs T; Mackroth MS
    Front Immunol; 2019; 10():2917. PubMed ID: 31921176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.
    Furtado R; Chorro L; Zimmerman N; Guillen E; Spaulding E; Chin SS; Daily JP; Lauvau G
    Front Immunol; 2020; 11():576743. PubMed ID: 33519801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface expression of inhibitory (CTLA-4) and stimulatory (OX40) receptors by CD4
    Gonçalves-Lopes RM; Lima NF; Carvalho KI; Scopel KK; Kallás EG; Ferreira MU
    Microbes Infect; 2016 Oct; 18(10):639-648. PubMed ID: 27320393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection.
    Butler NS; Moebius J; Pewe LL; Traore B; Doumbo OK; Tygrett LT; Waldschmidt TJ; Crompton PD; Harty JT
    Nat Immunol; 2011 Dec; 13(2):188-95. PubMed ID: 22157630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the Plasmodium falciparum malaria-specific CD4+ T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer.
    Schulte S; Heide J; Ackermann C; Peine S; Ramharter M; Mackroth MS; Woost R; Jacobs T; Schulze Zur Wiesch J
    Clin Exp Immunol; 2022 Apr; 207(2):227-236. PubMed ID: 35020841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of PD-1/LAG-3 and cytokine production by CD4(+) T cells during infection with Plasmodium parasites.
    Doe HT; Kimura D; Miyakoda M; Kimura K; Akbari M; Yui K
    Microbiol Immunol; 2016 Feb; 60(2):121-31. PubMed ID: 26696540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell responses to the Plasmodium falciparum erythrocyte membrane protein 1 in children with mild malaria.
    Gitau EN; Tuju J; Karanja H; Stevenson L; Requena P; Kimani E; Olotu A; Kimani D; Marsh K; Bull P; Urban BC
    J Immunol; 2014 Feb; 192(4):1753-61. PubMed ID: 24453249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced T cell activation in Plasmodium falciparum malaria-infected human immunodeficiency virus-1 patients from Mozambique.
    Chavale H; Santos-Oliveira JR; Da-Cruz AM; Enosse S
    Mem Inst Oswaldo Cruz; 2012 Dec; 107(8):985-92. PubMed ID: 23295747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Immune Checkpoint Blockade to Reverse HIV Latency.
    Van der Sluis RM; Kumar NA; Pascoe RD; Zerbato JM; Evans VA; Dantanarayana AI; Anderson JL; Sékaly RP; Fromentin R; Chomont N; Cameron PU; Lewin SR
    J Immunol; 2020 Mar; 204(5):1242-1254. PubMed ID: 31988180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent changes in the expression of regulatory cell surface ligands in activated human T-cells.
    Canaday DH; Parker KE; Aung H; Chen HE; Nunez-Medina D; Burant CJ
    BMC Immunol; 2013 Oct; 14():45. PubMed ID: 24083425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.